The psychosis spectrum in Parkinson disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

Prevalence and Characteristics of Dementia in Parkinson Disease

Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403

The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

Cummings, J. L., Isaacson, S., Mills, R., Williams, H., Chi‐Burris, K., Corbett, A., Dhall, R., & Ballard, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62106-6 · Cited by 954

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease

Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease

The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

Harding, A., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 609

Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

Minoshima, S., Foster, N. L., Sima, A. A. F., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001) · Annals of Neurology · doi:10.1002/ana.1133 · Cited by 560

Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group

Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

Aarsland, D., Ballard, C. G., Walker, Z., Boström, F., Alves, G. W., Kossakowski, K., Leroi, I., Pozo-Rodriguez, F., Minthon, L., & Londos, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70146-2 · Cited by 464

Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease

Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 454

Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations

Collerton, D., Perry, E. K., & McKeith, I. G. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000130 · Cited by 447

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD

Lobotesis, K., Fenwick, J. D., Phipps, A., Ryman, A., Swann, A., Ballard, C. G., McKeith, I. G., & O'Brien, J. T. (2001) · Neurology · doi:10.1212/wnl.56.5.643 · Cited by 405

A 12-Year Population-Based Study of Psychosis in Parkinson Disease

Forsaa, E. B., Larsen, J. P., Wentzel‐Larsen, T., Goetz, C. G., Stebbins, G. T., Aarsland, D., & Alves, G. W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.166 · Cited by 400

Predictors of dementia in Parkinson disease

Anang, J. B. M., Gagnon, J., Bertrand, J., Romenets, S. R., Latreille, V., Panisset, M., Montplaisir, J. Y., & Postuma, R. B. (2014) · Neurology · doi:10.1212/wnl.0000000000000842 · Cited by 379

Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up

Pollak, P. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029868 · Cited by 331

Epidemiology of psychosis in Parkinson's disease

Fénelon, G., & Alves, G. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.014 · Cited by 330

Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer’s Disease

Ballard, C. G., Holmes, C., McKeith, I. G., Neill, D., O'Brien, J. T., Cairns, N. J., Lantos, P. L., Perry, E. K., Ince, P. G., & Perry, R. H. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1039 · Cited by 312

Hallucinations in Parkinson disease

Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

Burn, D. J., Emre, M., McKeith, I. G., Deyn, P. P. D., Aarsland, D., Hsu, C., & Lane, R. M. (2006) · Movement Disorders · doi:10.1002/mds.21077 · Cited by 310

Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's disease

Ondo, W. G., Tintner, R., Voung, K. D., Lai, D., & Ringholz, G. M. (2005) · Movement Disorders · doi:10.1002/mds.20474 · Cited by 297

Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

Meltzer, H. Y., Mills, R., Revell, S., Williams, H., Johnson, A. D., Bahr, D., & Friedman, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.176 · Cited by 293

Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort

Winder‐Rhodes, S., Evans, J., Ban, M., Mason, S., Williams‐Gray, C. H., Foltynie, T., Durán, R., Mencacci, N. E., Sawcer, S. J., & Barker, R. A. (2013) · Brain · doi:10.1093/brain/aws318 · Cited by 292

Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model

Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2004) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290

Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease

Ballanger, B., Strafella, A. P., van Eimeren, T., Zurowski, M., Rusjan, P. M., Houle, S., & Fox, S. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.35 · Cited by 266

Visual hallucinatory syndromes and the anatomy of the visual brain

Santhouse, A. M. (2000) · Brain · doi:10.1093/brain/123.10.2055 · Cited by 262

Euro I nf: A M ulticenter C omparative O bservational S tudy of A pomorphine and L evodopa I nfusion in P arkinson's D isease

Martínez‐Martín, P., Reddy, P., Katzenschlager, R., Antonini, A., Todorova, A., Odin, P., Henriksen, T., Martin, A., Calandrella, D., Rizos, A., et al. (2014) · Movement Disorders · doi:10.1002/mds.26067 · Cited by 252

Olanzapine and clozapine

Goetz, C. G., Blasucci, L. M., Leurgans, S. E., & Pappert, E. J. (2000) · Neurology · doi:10.1212/wnl.55.6.789 · Cited by 249

Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

Pagonabarraga, J., Martinez‐Horta, S., Fernández de Bobadilla, R., Pérez, J., Ribosa‐Nogué, R., Marín, J., Pascual‐Sedano, B., García, C., Gironell, A., & Kulisevsky, J. (2016) · Movement Disorders · doi:10.1002/mds.26432 · Cited by 236

Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

Kurlan, R., Cummings, J. L., Raman, R., & Thal, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260060.60870.89 · Cited by 225

Visual symptoms in Parkinson's disease and Parkinson's disease dementia

Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23891 · Cited by 220

The changing face of Parkinson's disease‐associated psychosis: A cross‐sectional study based on the new NINDS‐NIMH criteria

Fénelon, G., Soulas, T., Zenasni, F., & de Langavant, L. C. (2010) · Movement Disorders · doi:10.1002/mds.22839 · Cited by 218

The association between motor subtypes and psychopathology in Parkinson's disease

Reijnders, J. S. A. M., Ehrt, U., Lousberg, R. L., Aarsland, D., & Leentjens, A. F. G. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.09.003 · Cited by 210

The hodology of hallucinations

Ffytche, D. H. (2008) · Cortex · doi:10.1016/j.cortex.2008.04.005 · Cited by 206

Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?

Shine, J. M., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2011) · Movement Disorders · doi:10.1002/mds.23896 · Cited by 205

Psychosis in Alzheimer’s Disease

Murray, P. S., Kumar, S., DeMichele‐Sweet, M. A. A., & Sweet, R. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.020 · Cited by 203

Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up

Pietz, K., Hagell, P., & Odin, P. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.709 · Cited by 200

Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci

Andreassen, O. A., Harbo, H. F., Wang, Y., Thompson, W. K., Schork, A. J., Mattingsdal, M., Zuber, V., Bettella, F., Ripke, S., Kelsoe, J. R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.195 · Cited by 200

Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s disease

Breier, A. F., Sutton, V. K., Feldman, P. D., Kadam, D. L., Ferchland, I., Wright, P., & Friedman, J. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01392-6 · Cited by 198

Decomposing the Neural Correlates of Antisaccade Eye Movements Using Event-Related fMRI

Ettinger, U., Ffytche, D. H., Kumari, V., Kathmann, N., Reuter, B., Zelaya, F. O., & Williams, S. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm147 · Cited by 198

Altered cortical visual processing in PD with hallucinations

Stebbins, G. T., Goetz, C. G., Carrillo, M. C., Bangen, K. J., Turner, D. A., Glover, G. H., & Gabrieli, J. D. E. (2004) · Neurology · doi:10.1212/01.wnl.0000141853.27081.bd · Cited by 189

Scales to assess psychosis in Parkinson's disease: Critique and recommendations

Fernandez, H. H., Aarsland, D., Fénelon, G., Friedman, J. H., Marsh, L., Tröster, A. I., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., et al. (2008) · Movement Disorders · doi:10.1002/mds.21875 · Cited by 188

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations

Meppelink, A. M., de Jong, B. M., Renken, R. J., Leenders, K. L., Cornelissen, F. W., & van Laar, T. (2009) · Brain · doi:10.1093/brain/awp223 · Cited by 183

Auditory hallucinations in Parkinson's disease

Inzelberg, R., Kipervasser, S., & Korczyn, A. D. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.533 · Cited by 179

Olanzapine treatment for dopaminergic‐induced hallucinations

Ondo, W. G., Levy, J. K., Vuong, K. D., Hunter, C., & Jankovic, J. J. (2002) · Movement Disorders · doi:10.1002/mds.10217 · Cited by 172

Intravenous levodopa in hallucinating Parkinson's disease patients

Goetz, C. G., Pappert, E. J., Blasucci, L. M., Stebbins, G. T., Ling, Z. D., Nora, M. V., & Carvey, P. M. (1998) · Neurology · doi:10.1212/wnl.50.2.515 · Cited by 170

Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease

Weintraub, D. A., Chiang, C., Kim, H. M., Wilkinson, J. R., Marras, C., Stanislawski, B., Mamikonyan, E., & Kales, H. C. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0031 · Cited by 169

A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia

McKinlay, A., Grace, R. C., Dalrymple‐Alford, J. C., Anderson, T., Fink, J., & Roger, D. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.05.009 · Cited by 164

Tricks of the mind: Visual hallucinations as disorders of attention

Shine, J. M., O’Callaghan, C., Halliday, G. M., & Lewis, S. J. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.004 · Cited by 162

The Malignant Course of “Benign Hallucinations” in Parkinson Disease

Goetz, C. G., Fan, W., Leurgans, S. E., Bernard, B. A., & Stebbins, G. T. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.713 · Cited by 161

The default mode network is disrupted in parkinson's disease with visual hallucinations

Yao, N., Chang, R. S., Cheung, C., Pang, S. Y.-Y., Lau, K. K., Suckling, J., Rowe, J. B., Yu, K., Mak, H. K., Chua, S.-E., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22577 · Cited by 155

Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson’s disease with hallucinations

Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B. A., Merkitch, D., deToledo‐Morrell, L., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awt360 · Cited by 155

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

Uc, E. Y., McDermott, M., Marder, K. S., Anderson, S. W., Litvan, I., Como, P. G., Auinger, P., Chou, K. L., & Growdon, J. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf992f · Cited by 154

Cerebral atrophy in Parkinson's disease patients with visual hallucinations

Ramírez‐Ruiz, B., Martí, M., TOLOSA, E. S., Giménez, M., Bargalló, N., Valldeoriola, F., & Junqué, C. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01768.x · Cited by 154

Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis

Wolters, E. C., Hurwitz, T. A., Mak, E., Teal, P. A., Peppard, F. R., Remick, R. A., Calne, S. M., & Calne, D. B. (1990) · Neurology · doi:10.1212/wnl.40.5.832 · Cited by 153

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease

Kalaitzakis, M. E., Christian, L., Moran, L. B., Graeber, M. B., Pearce, R. K. B., & Gentleman, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.007 · Cited by 150

Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus

Desikan, R. S., Schork, A. J., Wang, Y., Witoelar, A., Sharma, M., McEvoy, L. K., Holland, D., Brewer, J. B., Chen, C., Thompson, W. K., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.6 · Cited by 142

Testing an aetiological model of visual hallucinations in Parkinson's disease

Gallagher, D. A., Parkkinen, L., O’Sullivan, S. S., Spratt, A., Shah, A., Davey, C. C., Bremner, F., Révész, T., Williams, D. R., Lees, A. J., et al. (2011) · Brain · doi:10.1093/brain/awr225 · Cited by 140

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Shotbolt, P. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5335 · Cited by 140

Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations

Oishi, N., Udaka, F., Kameyama, M., Sawamoto, N., Hashikawa, K., & Fukuyama, H. (2005) · Neurology · doi:10.1212/01.wnl.0000187116.13370.e0 · Cited by 137

A semi‐structured interview to assess visual hallucinations in older people

Mosimann, U. P., Collerton, D., Dudley, R. E. J., Meyer, T. D., Graham, G., Dean, J. L., Bearn, D., Killen, A., Dickinson, L., Clarke, M. P., et al. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1965 · Cited by 135

Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia

Ibarretxe‐Bilbao, N., Ramírez‐Ruiz, B., Tolosa, E., Martı́, M. J., Valldeoriola, F., Bargalló, N., & Junqué, C. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0885-8 · Cited by 134

The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease

Shine, J. M., Halliday, G. M., Gilat, M., Matar, E., Bolitho, S., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2013) · Human Brain Mapping · doi:10.1002/hbm.22321 · Cited by 133

Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

Ibarretxe‐Bilbao, N., Ramírez‐Ruiz, B., Junqué, C., Martí, M. J., Valldeoriola, F., Bargalló, N., Juanes, S., & Tolosa, E. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.179655 · Cited by 133

Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease

Ravina, B. M., MAREK, K. L., Eberly, S. W., Oakes, D., Kurlan, R., Ascherio, A., Beal, F. M., Beck, J. C., Flagg, E., Galpern, W. R., et al. (2012) · Movement Disorders · doi:10.1002/mds.25157 · Cited by 133

Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up

ONOFRJ, M. C., Thomas, A., D’Andreamatteo, G., Iacono, D., Luciano, A. L., Rollo, A. D., Mascio, R. D., Ballone, E., & Iorio, A. D. (2002) · Neurological Sciences · doi:10.1007/s100720200085 · Cited by 131

Hallucinators find meaning in noises: Pareidolic illusions in dementia with Lewy bodies

Yokoi, K., Nishio, Y., Uchiyama, M., Shimomura, T., Iizuka, O., & Mori, E. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.01.017 · Cited by 130

Prevalence of Psychotic Symptoms in a Community-Based Parkinson Disease Sample

Mack, J., Rabins, P. V., Anderson, K. E., Goldstein, S. R., Grill, S. E., Hirsch, E. S., Lehmann, S. W., Little, J. T., Margolis, R. L., Palanci, J. M., et al. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31821f1b41 · Cited by 128

Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia

Sánchez‐Castañeda, C., Reñé, R., Ramírez‐Ruiz, B., Campdelacreu, J., Gascón, J., Falcón, C., Calopa, M., Jaumà, S., Juncadella, M., & Junqué, C. (2010) · Movement Disorders · doi:10.1002/mds.22873 · Cited by 127

l -Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

Kaiser, R., Höfer, A., Grapengiesser, A., Gasser, T., Kupsch, A. R., Roots, I., & Brockmöller, J. (2003) · Neurology · doi:10.1212/01.wnl.0000068009.32067.a1 · Cited by 126

Feeling of presence in Parkinson's disease

Fénelon, G., Soulas, T., de Langavant, L. C., Trinkler, I., & Bachoud‐Lévi, A. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.234799 · Cited by 126

Course of psychiatric symptoms and global cognition in early Parkinson disease

de la Riva, P., Smith, K. M., Xie, S. X., & Weintraub, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000801 · Cited by 123

Metabolic Alterations in Patients With Parkinson Disease and Visual Hallucinations

Boecker, H., Ceballos-Baumann, A., Volk, D., Conrad, B., Förstl, H., & Häussermann, P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.984 · Cited by 123

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease

Lee, J., Kim, J. M., Ahn, J., Kim, H., Jeon, B. S., & Kim, T. W. (2013) · Movement Disorders · doi:10.1002/mds.25543 · Cited by 122

Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease

Manganelli, F., Vitale, C., Santangelo, G., Pisciotta, C., Iodice, R., Cozzolino, A., Dubbioso, R., Picillo, M., Barone, P., & Santoro, L. (2009) · Brain · doi:10.1093/brain/awp166 · Cited by 122

The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study

Janzen, J., Ent, D. V. ‘., Lemstra, A. W., Berendse, H. W., Barkhof, F., & Foncke, E. M. J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6149-z · Cited by 120

Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4‐year study

Gibson, G., Mottram, P. G., Burn, D. J., Hindle, J. V., Landau, S., Samuel, M., Hurt, C. S., Brown, R. G., & Wilson, K. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3869 · Cited by 117

Visual hallucinatory syndromes: past, present, and future

Ffytche, D. H. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.2/dffytche · Cited by 116

Neuropsychological deficits in Parkinson's disease patients with visual hallucinations

Ramírez‐Ruiz, B., Junqué, C., Martı́, M. J., Valldeoriola, F., & TOLOSA, E. S. (2006) · Movement Disorders · doi:10.1002/mds.20965 · Cited by 112

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease

Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B. K., Nation, D., Guevara, A., & Levin, B. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-21 · Cited by 111

Visual complaints and visual hallucinations in Parkinson's disease

Urwyler, P., Nef, T., Killen, A., Collerton, D., Thomas, A. J., Burn, D. J., McKeith, I. G., & Mosimann, U. P. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.12.009 · Cited by 107

Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review

Lenka, A., Jhunjhunwala, K. R., Saini, J., & Pal, P. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.005 · Cited by 106

Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease

Oeda, T., Umemura, A., Mori, Y., Tomita, S., Kohsaka, M., Park, K., Inoue, K., Fujimura, H., Hasegawa, H., Sugiyama, H., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.027 · Cited by 106

Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms

Fénelon, G. (2008) · CNS Spectrums · doi:10.1017/s1092852900017284 · Cited by 106

Visual hallucination in Parkinson's disease with FDG PET

Nagano‐Saito, A., Washimi, Y., Arahata, Y., Iwai, K., Kawatsu, S., Ito, K., Nakamura, A., Abe, Y., Yamada, T., Kato, T., et al. (2004) · Movement Disorders · doi:10.1002/mds.20129 · Cited by 105

Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations

Ramírez‐Ruiz, B., Junqué, C., Martı́, M. J., Valldeoriola, F., & TOLOSA, E. S. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100850 · Cited by 104

Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease

Pagonabarraga, J., Soriano‐Mas, C., Llebaria, G., López‐Solà, M., Pujol, J., & Kulisevsky, J. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.11.017 · Cited by 103

Visual Hallucinations in PD and Lewy Body Dementias: Old and New Hypotheses

ONOFRJ, M. C., Taylor, J., Monaco, D., Franciotti, R., Anzellotti, F., Bonanni, L., Onofrj, V., & Thomas, A. (2013) · Behavioural Neurology · doi:10.1155/2013/703924 · Cited by 103

Parkinson’s disease psychosis 2010: A review article

Friedman, J. H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.05.004 · Cited by 99

Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression

Morgante, L., Colosimo, C., Antonini, A., Marconi, R., Meco, G., Pederzoli, M., Pontieri, F. E., Cicarelli, G., Abbruzzese, G., Zappulla, S., et al. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300043 · Cited by 99

Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations

Papapetropoulos, S., McCorquodale, D. S., Gonzalez, J., Jean-Gilles, L., & Mash, D. C. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.10.005 · Cited by 98

Parkinson Disease Psychosis: Update

Friedman, J. H. (2013) · Behavioural Neurology · doi:10.1155/2013/645429 · Cited by 98

Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations

Shine, J. M., Keogh, R., O'Callaghan, C., Muller, A. J., Lewis, S. J. G., & Pearson, J. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.2047 · Cited by 97

Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study

Zhu, K., van Hilten, J. J., Putter, H., & Marinus, J. (2013) · Movement Disorders · doi:10.1002/mds.25389 · Cited by 93

Cortical and subcortical brain atrophy in Parkinson's disease with visual hallucination

Watanabe, H., Senda, J., Kato, S., Ito, M., Atsuta, N., Hara, K., Tsuboi, T., Katsuno, M., Nakamura, T., Hirayama, M., et al. (2013) · Movement Disorders · doi:10.1002/mds.25641 · Cited by 92

Executive functions are impaired in patients with Parkinson's disease with visual hallucinations

Barnes, J., & Boubert, L. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.116202 · Cited by 91

Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

Goetz, C. G., Stebbins, G. T., & Ouyang, B. (2011) · Movement Disorders · doi:10.1002/mds.23835 · Cited by 91

Brain response to complex visual stimuli in Parkinson's patients with hallucinations: A functional magnetic resonance imaging study

Ramírez‐Ruiz, B., Martı́, M. J., TOLOSA, E. S., Falcón, C., Bargalló, N., Valldeoriola, F., & Junqué, C. (2008) · Movement Disorders · doi:10.1002/mds.22258 · Cited by 89

Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis

Voss, T., Bahr, D., Cummings, J. L., Mills, R., Ravina, B. M., & Williams, H. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.10.022 · Cited by 85

Drug-Induced Psychosis in Parkinson Disease

Chou, K. L., Messing, S. P., Oakes, D., Feldman, P. D., Breier, A. F., & Friedman, J. H. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000180228.77802.32 · Cited by 85

Visual hallucinations in Parkinson's disease: Theoretical models

Muller, A. J., Shine, J. M., Halliday, G. M., & Lewis, S. J. G. (2014) · Movement Disorders · doi:10.1002/mds.26004 · Cited by 85

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.

MAKOFF, A. J., Graham, J., Arranz, M. J., Forsyth, J., Li, T., Aitchison, K. J., Shaikh, S., & Grünewald, R. A. (2000) · Pharmacogenetics · doi:10.1097/00008571-200002000-00006 · Cited by 85

Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses

ONOFRJ, M. C., Taylor, J., Monaco, D., et al. (2012) · PubMed · doi:10.25405/ncl.34194777 · Cited by 84

Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease

Li, Y., Sekine, T., Funayama, M., Li, L., Yoshino, H., Nishioka, K., Tomiyama, H., & Hattori, N. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.019 · Cited by 83

Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy

Marco, E. V. D., Annesi, G., Tarantino, P., Rocca, F. E., Provenzano, G., Civitelli, D., Candiano, I. C. C., Annesi, F., Carrideo, S., Condino, F., et al. (2007) · Movement Disorders · doi:10.1002/mds.21892 · Cited by 83

Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease

Shin, S., Lee, J. E., Hong, J. Y., Sunwoo, M.-K., Sohn, Y. H., & Lee, P. H. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303391 · Cited by 83

Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease

Llebaria, G., Pagonabarraga, J., Martínez‐Corral, M., García‐Sánchez, C., Pascual‐Sedano, B., Gironell, A., & Kulisevsky, J. (2010) · Movement Disorders · doi:10.1002/mds.23411 · Cited by 79

Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients

Grossi, D., Trojano, L., Pellecchia, M. T., Amboni, M., Fragassi, N. A., & Barone, P. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1339 · Cited by 74

Marked Improvement of Psychotic Symptoms After Electroconvulsive Therapy in Parkinson Disease

Ueda, S., Koyama, K., & Okubo, Y. (2010) · Journal of Ect · doi:10.1097/yct.0b013e3181c18a3d · Cited by 72

Preliminary fMRI Evidence of Visual System Dysfunction in Parkinson's Disease Patients With Visual Hallucinations

Holroyd, S., & Wooten, G. F. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.402 · Cited by 72

Visual hallucinations in eye disease

Ffytche, D. H. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32831f1b3f · Cited by 69

Resting activity in visual and corticostriatal pathways in Parkinson's disease with hallucinations

Yao, N., Pang, S. Y.-Y., Cheung, C., Chang, R. S., Lau, K. K., Suckling, J., Yu, K., Mak, H. K., McAlonan, G. M., Ho, S., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.11.020 · Cited by 69

Are patients with Parkinson’s disease blind to blindsight?

Diederich, N. J., Stebbins, G. T., Schiltz, C., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awu094 · Cited by 69

Disease‐related and genetic correlates of psychotic symptoms in Parkinson's disease

Factor, S. A., Steenland, N. K., Higgins, D. S., Molho, E., Kay, D. M., Montimurro, J. S., Rosen, A. R., Zabetian, C. P., & Payami, H. (2011) · Movement Disorders · doi:10.1002/mds.23806 · Cited by 68

Cognitive correlates of hallucinations and delusions in Parkinson's disease

Factor, S. A., Scullin, M. K., Sollinger, A. B., Land, J. O., Wood‐Siverio, C., Zanders, L., Freeman, A., Bliwise, D. L., McDonald, W. M., & Goldstein, F. C. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.10.033 · Cited by 67

Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: A review

Lenka, A., Hegde, S., Jhunjhunwala, K. R., & Pal, P. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.11.018 · Cited by 66

Parkinson disease psychosis: Update.

Friedman, J. H. (2013) · PubMed · doi:10.3233/ben-129016 · Cited by 65

On visual hallucinations and cortical networks: a trans-diagnostic review

Carter, R., & Ffytche, D. H. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7687-6 · Cited by 65

I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging

Goetz, C. G., Vaughan, C. L., Goldman, J. G., & Stebbins, G. T. (2013) · Movement Disorders · doi:10.1002/mds.25554 · Cited by 64

Medication-induced hallucination and cerebral blood flow in Parkinson's disease

Okada, K., D, N. S. M., Kobayashi, S., Oguro, H., & Yamaguchi, S. (1999) · Journal of Neurology · doi:10.1007/s004150050364 · Cited by 64

Foveal vision is impaired in Parkinson's disease

Bodis-Wollner, I. G. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.012 · Cited by 64

Visual object recognition and attention in Parkinson's disease patients with visual hallucinations

Meppelink, A. M., Koerts, J., Borg, M., Leenders, K. L., & van Laar, T. (2008) · Movement Disorders · doi:10.1002/mds.22270 · Cited by 64

Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease

Wang, J., Si, Y.-M., Liu, Z.-L., & Yu, L. (2003) · Pharmacogenetics · doi:10.1097/00008571-200306000-00008 · Cited by 61

Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies

Kurita, A., Murakami, M., Takagi, S., Matsushima, M., & Suzuki, M. (2010) · Movement Disorders · doi:10.1002/mds.22919 · Cited by 61

Visual hallucinations in Parkinson's disease: Clues to separate origins

ONOFRJ, M. C., Bonanni, L., Albani, G., Mauro, A., Bulla, D., & Thomas, A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.025 · Cited by 60

Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy

Usui, C., Hatta, K., Doi, N., Kubo, S., Kamigaichi, R., Nakanishi, A., Nakamura, H., Hattori, N., & Arai, H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.003 · Cited by 60

Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations

van Laar, T., Postma, A. G., & Drent, M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.05.006 · Cited by 59

Cognitive impairment patterns in Parkinson’s disease with visual hallucinations

Özer, F., Meral, H., Hanoğlu, L., Öztürk, O., Özcan, T. A., Çetin, S. E., Atmaca, B., & Tıraş, R. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.05.006 · Cited by 59

Dopamine agonists and delusional jealousy in Parkinson's disease: A cross‐sectional prevalence study

Poletti, M., Perugi, G., Logi, C., Romano, A., Dotto, P. D., Ceravolo, R., Rossi, G., Pepe, P., Dell’Osso, L., & Bonuccelli, U. (2012) · Movement Disorders · doi:10.1002/mds.25129 · Cited by 57

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations

Jacobson, S. A., Morshed, T., Dugger, B. N., Beach, T. G., Hentz, J. G., Adler, C. H., Shill, H. A., Sabbagh, M. N., Belden, C. M., Sue, L. I., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.018 · Cited by 57

Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

Ballard, C. G., Isaacson, S., Mills, R., Williams, H., Corbett, A., Coate, B., Pahwa, R., Rascol, O., & Burn, D. J. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.06.021 · Cited by 57

Apolipoprotein E ϵ4 and catechol‐O‐methyltransferase alleles in autopsy‐proven Parkinson's disease: Relationship to dementia and hallucinations

Camicioli, R. M., Rajput, A. H., Rajput, M., Reece, C., Payami, H., Hao, C., & Rajput, A. H. (2005) · Movement Disorders · doi:10.1002/mds.20481 · Cited by 57

Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence

Borgemeester, R. W. K., Lees, A. J., & van Laar, T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.04.023 · Cited by 57

Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania

Dotchin, C. L., Jusabani, A., & Walker, R. W. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.11.013 · Cited by 55

Attentional and perceptual impairments in Parkinson's disease with visual hallucinations

Koerts, J., Borg, M., Meppelink, A. M., Leenders, K. L., van Beilen, M., & van Laar, T. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.01.003 · Cited by 54

Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

Gasca‐Salas, C., Clavero, P., García‐García, D., Obeso, J. A., & Rodríguez‐Oroz, M. (2015) · Human Brain Mapping · doi:10.1002/hbm.23080 · Cited by 54

Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm

Shine, J. M., Halliday, G. M., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2012) · Movement Disorders · doi:10.1002/mds.24900 · Cited by 53

Attention and visual dysfunction in Parkinson's disease

Botha, H., & Carr, J. A. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.03.004 · Cited by 53

Genetic Polymorphisms in Parkinson Disease Subjects With and Without Hallucinations

Goldman, J. G., Goetz, C. G., Berry‐Kravis, E., Leurgans, S. E., & Zhou, L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1280 · Cited by 53

Hallucinations and psychosis in Parkinson's disease

Rabey, J. M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70846-6 · Cited by 53

Subcutaneous apomorphine and non-motor symptoms in Parkinson's disease

Todorova, A., & Chaudhuri, К. R. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.08.012 · Cited by 53

Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations

Meppelink, A. M., de Jong, B. M., Teune, L. K., & van Laar, T. (2010) · Movement Disorders · doi:10.1002/mds.23375 · Cited by 53

Genetic polymorphism of the angiotensin converting enzyme and l-dopa-induced adverse effects in Parkinson's disease

Lin, J.-J., Yueh, K.-C., Lin, S., Harn, H., & Liu, J.-T. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.10.018 · Cited by 52

Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status

Monsell, S. E., Besser, L. M., Heller, K., Checkoway, H., Litvan, I., & Kukull, W. A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.001 · Cited by 52

Phenotypic associations of tau and ApoE in Parkinson's disease

Papapetropoulos, S., Farrer, M. J., Stone, J. T., Milkovic, N. M., Ross, O. A., Calvo, L., McQuorquodale, D., & Mash, D. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.008 · Cited by 52

Cerebral basis of visual hallucinations in Parkinson's disease: Structural and functional MRI studies

Ibarretxe‐Bilbao, N., Junqué, C., Martı́, M. J., & TOLOSA, E. S. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.06.019 · Cited by 50

The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.

de la Fuente‐Fernández, R., Nunez, M., & López, E. (1999) · PubMed · Cited by 48

Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease

Fujii, C., Harada, S., Ohkoshi, N., Hayashi, A., Yoshizawa, K., 石塚, 千., & Nakamura, T. K. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.560508.x · Cited by 47

A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia

Pagonabarraga, J., Llebaria, G., García‐Sánchez, C., Pascual‐Sedano, B., Gironell, A., & Kulisevsky, J. (2007) · Movement Disorders · doi:10.1002/mds.21864 · Cited by 46

New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease

Goetz, C. G. (2010) · Movement Disorders · doi:10.1002/mds.22636 · Cited by 45

Executive dysfunction in non-demented Parkinson’s disease patients with hallucinations

Imamura, K., Wada‐Isoe, K., Kitayama, M., & Nakashima, K. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00933.x · Cited by 45

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients

Wood, R. A., Hopkins, S. A., Moodley, K. K., & Chan, D. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00263 · Cited by 42

Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults

Nho, K., Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-148009 · Cited by 41

Apolipoprotein e4 advances appearance of psychosis in patients with Parkinson's disease

Feldman, B., Chapman, J., & Korczyn, A. D. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00535.x · Cited by 41

Structural brain abnormalities in patients with Parkinson’s disease with visual hallucinations: A comparative voxel-based analysis

Gama, R. L., de Bruin, V. M. S., Távora, D. G. F., Duran, F., Bittencourt, L., & Tufik, S. B. (2014) · Brain and Cognition · doi:10.1016/j.bandc.2014.03.011 · Cited by 39

Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease

Wang, J., Zhao, C., Chen, B., & Liu, Z.-L. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.006 · Cited by 39

Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson’s disease

Hirayama, M., Nakamura, T., Watanabe, H., Uchida, K., Hama, T., Hara, T., Niimi, Y., Ito, M., Ohno, K., & Sobue, G. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.11.004 · Cited by 38

Selective diplopia in Parkinson's disease: A special subtype of visual hallucination?

Nebe, A., & Ebersbach, G. (2007) · Movement Disorders · doi:10.1002/mds.21298 · Cited by 38

Visual Hallucinations and Cognitive Impairment in Parkinson's Disease

Park, H. K., Kim, J. S., Im, K. C., Kim, M. J., Lee, J., Lee, M. C., Kim, J., & Chung, S. J. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100014888 · Cited by 36

Genetic substrates of psychosis in patients with Parkinson's disease: A critical review

Lenka, A., Arumugham, S. S., Christopher, R., & Pal, P. K. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.005 · Cited by 36

Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease

Moro, A., Munhoz, R. P., Moscovich, M., Arruda, W. O., & Teive, H. A. G. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.04.021 · Cited by 34

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson’s disease patients

Schuh, A. F. S., Altmann, V., Rieck, M., Tovo‐Rodrigues, L., Monte, T. L., Callegari-Jacques, S. M., Medeiros, M. S., Rieder, C. R. D. M., & Hutz, M. H. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.37 · Cited by 33

The relationship between hallucinations and FDG-PET in dementia with Lewy bodies

Firbank, M. J., Lloyd, J. J., & O'Brien, J. T. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9434-0 · Cited by 31

Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes

Kiferle, L., Ceravolo, R., Petrozzi, L., Rossi, C. A., Frosini, D., Rocchi, A., Siciliano, G., Bonuccelli, U., & Murri, L. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.028 · Cited by 31

Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease

Meral, H., Özcan, T. A., Özer, F., Öztürk, O., Özben, S., Erol, C., Çetin, S. E., Hanoğlu, L., Ozkayran, T., & Yilsen, M. (2007) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.08.010 · Cited by 30

The Relation Between Visual Hallucinations and Visual Evoked Potential in Parkinson Disease

Matsui, H., Udaka, F., Tamura, A., Oda, M., Kubori, T., Nishinaka, K., & Kameyama, M. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000157066.50948.65 · Cited by 29

Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease

Huot, P., Johnston, T. H., Visanji, N. P., Darr, T., Pires, D., Hazrati, L., Brotchie, J. M., & Fox, S. H. (2012) · Movement Disorders · doi:10.1002/mds.24964 · Cited by 29

Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of l-dopa-induced adverse effects

Pascale, E., Purcaro, C., Passarelli, E., Guglielmi, R., Vestri, A. R., Passarelli, F., & Meco, G. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.017 · Cited by 28

HOMER1 Promoter Analysis in Parkinson’s Disease: Association Study with Psychotic Symptoms

Luca, V. D., Annesi, G., Marco, E. V. D., de Bartolomeis, A., Nicoletti, G., Pugliese, P., Muscettola, G., Barone, P., & Quattrone, A. (2009) · Neuropsychobiology · doi:10.1159/000230689 · Cited by 27

Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease

Schuh, A. F. S., Francisconi, C. L. M., Altmann, V., Monte, T. L., Callegari-Jacques, S. M., Rieder, C. R. D. M., & Hutz, M. H. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001666 · Cited by 27

Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias

Creese, B., Ballard, C. G., Aarsland, D., Londos, E., Sharp, S. I., & Jones, E. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.11.001 · Cited by 25

The Effects of Apomorphine on Visual Perception in Patients With Parkinson Disease and Visual Hallucinations

Geerligs, L., Meppelink, A. M., Brouwer, W., & van Laar, T. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181a6a92b · Cited by 23

Multi-Modal Hallucinations and Cognitive Function in Parkinson’s Disease

Katzen, H., Myerson, C., Papapetropoulos, S., Nahab, F. B., Gallo, B. V., & Levin, B. E. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000314875 · Cited by 23

Fast Facts: Parkinson's Disease

Chaudhuri, К. R., & Fung, V. S. C. (2016) · KARGER eBooks · doi:10.1159/isbn.978-1-910797-22-8 · Cited by 23

Visual hallucinations, white matter lesions and disease severity in Parkinson's disease

Kraft, E., Winkelmann, J., Trenkwalder, C., & Auer, D. P. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb07365.x · Cited by 19

Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations

Goldman, J. G., Marr, D., Zhou, L., Ouyang, B., Leurgans, S. E., Berry‐Kravis, E., & Goetz, C. G. (2011) · Movement Disorders · doi:10.1002/mds.23655 · Cited by 18

Risk factors for visual hallucinations in patients with Parkinson’s disease

Gama, R. L., de Bruin, V. M. S., de Bruin, P. F. C., Távora, D. G. F., Lopes, E. M. S., Jorge, I. F., Bittencourt, L., & Tufik, S. B. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000418 · Cited by 17

Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease

Rana, A. Q., Vaid, H. M., Edun, A., Doğu, O., & Rana, M. A. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.007 · Cited by 16

Cognitive correlates of psychosis in patients with Parkinson's disease

Moustafa, A. A., Krishna, R., Frank, M. J., Eissa, A. M., & Hewedi, D. H. (2014) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2013.877385 · Cited by 16

Increased temporal blood flow associated with visual hallucinations in Parkinson's disease with dementia

Kataoka, H., Furiya, Y., Morikawa, M., Ueno, S., & Inoue, M. (2007) · Movement Disorders · doi:10.1002/mds.21923 · Cited by 16

Why psychosis is frequently associated with Parkinson's disease?

Zhong, J., Wu, S., Zhao, Y. H., Chen, H., Zhao, N.-W., Zheng, K.-W., Zhao, Z., Chen, W. K., Wang, B., & Wu, K. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.27.006 · Cited by 14

An artist's view of drug‐induced hallucinosis

Ebersbach, G. (2003) · Movement Disorders · doi:10.1002/mds.10437 · Cited by 14

Visual Memory Errors in Parkinson's Disease Patient With Visual Hallucinations

Barnes, J., & Boubert, L. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.539308 · Cited by 13

Phenomenology of Visual Hallucinations and Their Relationship to Cognitive Profile in Parkinson’s Disease Patients

Boubert, L., & Barnes, J. (2015) · SAGE Open · doi:10.1177/2158244015585827 · Cited by 12

No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias

Creese, B., Ballard, C. G., Aarsland, D., Londos, E., Sharp, S. I., & Jones, E. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.062 · Cited by 7

Editorial on: Pagonabarraga J, Martinez‐Hora S, Fernandez de Bobadilla R et al. Minor hallucinations occur in drug‐naïve Parkinson's disease patients even from the premotor phase. Movement Disorders 2015; Available from: DOI: 10.1002/mds.26432

Friedman, J. H. (2015) · Movement Disorders · doi:10.1002/mds.26472 · Cited by 6

A comparison of Montreal Cognitive Assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease

Chung, E. J., Seok, K., & Kim, S. J. (2015) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2014.12.022 · Cited by 4

Genetic Variation Analysis in Parkinson Disease Patients With and Without Hallucinations

Goetz, C. G., Burke, P. F., Leurgans, S. E., Berry‐Kravis, E., Blasucci, L. M., Raman, R., & Zhou, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.209

The neuropsychiatry of Parkinson's disease: advances and challenges

Weintraub, D., Aarsland, D., Chaudhuri, К. R., Dobkin, R. D., Leentjens, A. F. G., Rodriguez-Violante, M., & Schrag, A. E. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00330-6 · Cited by 480

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?

Jellinger, K. A., & Korczyn, A. D. (2018) · BMC Medicine · doi:10.1186/s12916-018-1016-8 · Cited by 406

Network connectivity determines cortical thinning in early Parkinson’s disease progression

Yau, Y. H. C., Zeighami, Y., Baker, T. E., Larcher, K. M.-H., Vainik, U., Dadar, M., Fonov, V., Hagmann, P., Griffa, A., Mišić, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02416-0 · Cited by 266

The sinister face of heme oxygenase-1 in brain aging and disease

Schipper, H. M., Song, W., Tavitian, A., & Cressatti, M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.008 · Cited by 206

The neuropsychiatry of Parkinson's disease: advances and challenges

Weintraub, D., Aarsland, D., Chaudhuri, К. R., Dobkin, R., Leentjens, A., Rodriguez-Violante, M., & Schrag, A. E. (2022) · UCL Discovery (University College London) · Cited by 181

Psychosis in Parkinson's Disease

Ffytche, D. H., & Aarsland, D. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.04.005 · Cited by 45

P.8.a.013 The challenge of subject selection in clinical trials

Detke, M. J., Williams, J. B. W., Kobak, K. A., Ellis, A., Giller, E. L., Brown, B., Reines, S. A., Kane, J., & Popp, D. (2011) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(11)71011-2

Psychosis and Parkinson’s Disease

Jakel, R. J., & Stacy, M. A. (2012) · Advances in biological psychiatry · doi:10.1159/000331526 · Cited by 2

Psychosis in Parkinson’s disease: a clinical biomarker of disease stage and prognosis

Pinho, M., Martins, D. O., Martins, P. S., Gomes, L., & Carvalho, S. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.1985

Psychotic symptoms in Parkinson’s disease

Papapetropoulos, S., & Mash, D. C. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0918-5 · Cited by 112